VTCN1 and cancer: In contrast to blocking B7-H4 in order to potentiate T cell activity and cancer prognosis, we propose that in HIV/CMV co-infected individuals following immune reconstitution, B7-H4 serves as regulator of immune activation without compromising CMV immunity.